Zai Lab (ZLAB) EBT (2020 - 2026)

Zai Lab has disclosed EBT across 7 years of filings, most recently posting -$49.6 million for Q1 2026.

• EBT for Q1 2026 came in at -$49.6 million, down 2.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$179.6 million (up 28.75% YoY), and the FY2025 annual result was -$178.5 million, up 30.59% from the prior year.
• EBT came in at -$49.6 million for Q1 2026 at Zai Lab, up from -$53.3 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$36.0 million in Q3 2025 to a low of -$161.2 million in Q3 2022.
• The 5-year median for EBT is -$61.8 million (2022), against an average of -$74.3 million.
• Peak annual rise in EBT reached 70.77% in 2022, while the deepest fall reached 67.78% in 2022.
• Zai Lab's EBT stood at -$61.8 million in 2022, then plunged by 54.49% to -$95.4 million in 2023, then climbed by 14.4% to -$81.7 million in 2024, then jumped by 34.7% to -$53.3 million in 2025, then rose by 7.05% to -$49.6 million in 2026.
• The last three EBT figures came in at -$49.6 million (Q1 2026), -$53.3 million (Q4 2025), and -$36.0 million (Q3 2025), per Business Quant data.